Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
3.020
+0.020 (0.67%)
At close: Mar 6, 2026, 4:00 PM EST
3.060
+0.040 (1.32%)
After-hours: Mar 6, 2026, 6:43 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $513.21 million as of March 6, 2026. Its market cap has increased by 85.77% in one year.
Market Cap
513.21M
Enterprise Value
361.78M
1-Year Change
85.77%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $513.21M, a decrease of -80.13%. That is a compound annual growth rate of -47.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 513.21M | 68.72% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 539.54M |
| Rigel Pharmaceuticals | 538.73M |
| Altimmune | 538.50M |
| Prothena Corporation | 533.48M |
| Lexeo Therapeutics | 532.44M |
| ADC Therapeutics | 530.19M |
| Rocket Pharmaceuticals | 521.13M |
| Tectonic Therapeutic | 516.08M |